The Selective Serotonin Reuptake Inhibitor Sertraline: Its Profile and Use in Psychiatric Disorders - Wikidata - wikimedia - TriplyDB

The Selective Serotonin Reuptake Inhibitor Sertraline: Its Profile and Use in Psychiatric Disorders

The Selective Serotonin Reuptake Inhibitor Sertraline: Its Profile and Use in Psychiatric Disorders

http://www.wikidata.org/entity/Q56016702

about

Sertraline versus other antidepressive agents for depression Sertraline versus other antidepressive agents for depression Circuit to construct mapping: a mathematical tool for assisting the diagnosis and treatment in major depressive disorder The safety of SSRIs in generalised anxiety disorder: any reason to be anxious?Treatment of premenstrual dysphoric disorder with luteal phase dosing of sertraline.Psychopharmacology in psychodermatology.Evaluation of the pharmacokinetics, safety and clinical efficacy of sertraline used to treat social anxiety.Effect of sertraline on complications and survival after hematopoietic stem-cell transplantation, a double-blind, placebo-controlled clinical study.Sertraline for social anxiety disorder.Significant reduction of sertraline plasma levels by carbamazepine and phenytoin.Analysis of sertraline in postmortem fluids and tissues in 11 aviation accident victims.

P2860

Q24235928-35E596D6-0F70-48F0-B2B7-A6EAB1E6A917 Q24241023-722A353A-243A-4038-9C99-FA8911B471A1 Q28085697-242E1D10-BACD-4256-8FA0-472312B323FE Q35208413-9842B3F5-192E-4F60-8622-67543761C337 Q35575008-0BF420A9-7843-4434-9719-4B4AD0429877 Q37422575-0E020F9D-7D0D-4CC3-8C3F-BB01B091F923 Q38120061-2066E422-6BF7-41C4-AC0A-687C59472562 Q40090575-53C70047-EB81-4DD0-BAE4-AD6E827BE52B Q43265622-17F9C989-6690-4EDB-9224-7F0682F280AE Q43949974-2C8C657D-ADAA-4B9F-AA03-2E906DBC4814 Q48118637-58A19A4D-6CB5-4A9F-B2A4-0CE2780A0859

P2860

The Selective Serotonin Reuptake Inhibitor Sertraline: Its Profile and Use in Psychiatric Disorders

http://www.wikidata.org/entity/Q56016702

description

im Juni 2006 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в червні 2006

@uk

name

The Selective Serotonin Reupta ...... d Use in Psychiatric Disorders

@en

The Selective Serotonin Reupta ...... d Use in Psychiatric Disorders

@nl

type

label

The Selective Serotonin Reupta ...... d Use in Psychiatric Disorders

@en

The Selective Serotonin Reupta ...... d Use in Psychiatric Disorders

@nl

prefLabel

The Selective Serotonin Reupta ...... d Use in Psychiatric Disorders

@en

The Selective Serotonin Reupta ...... d Use in Psychiatric Disorders

@nl

P1433

Q56016702-372B1BEF-E76A-441F-9B30-F6F07BA3B527

P1476

Q56016702-93310825-EE56-4B9E-8B74-A7E69511F6C9

P2093

Q56016702-601621BE-517B-49DC-A34C-F9938F120531

Q56016702-EAF78327-C8A6-4A4C-A084-5FC29CC33EFB

Q56016702-EEB4B02D-5C49-4678-A78F-B5E9CA9F0A09

P2860

Q56016702-0AE905D0-77FC-4336-8309-B14765650DA9

Q56016702-194AFB4D-DF43-426D-832F-126A6E499B40

Q56016702-436BF354-726A-4969-8EB4-B2ED43B9613A

Q56016702-534CA780-01F3-4DCB-98DE-B1A0138FBEEE

Q56016702-55E84A3C-F0CA-456D-A75F-2312B3EE631F

Q56016702-66BF3A58-4A6D-4FC1-8B96-903419F7CE3D

Q56016702-7E0882D3-385C-4B8E-B873-CE765E637732

Q56016702-81F6F259-3358-4719-8008-745746B96DFF

Q56016702-86284EBF-0CA3-4F24-A2A7-D939FBE7E808

Q56016702-95409869-A1DD-4136-97D3-6BBB5E58DD7F

P304

Q56016702-A7B73F10-DE8B-4D34-96DC-C364F0E5CA0A

P31

Q56016702-35AFABAC-AB72-4B28-81FB-5201545B46A4

P356

Q56016702-055A4D34-1361-4C88-B3C7-2D25ED52A831

P433

Q56016702-806866CD-5D04-47FF-A0D4-A24333C3ADE3

P478

Q56016702-C06402EB-2295-4537-B11C-4360D450D594

P577

Q56016702-07A5568A-0D74-4FF4-BE14-B9782AD79FA8

P5875

Q56016702-288088AE-0C73-4C3B-8D66-106E4B8B3F14

P921

Q56016702-171c52fc-830c-4077-b77e-cbb3862efcfb

P356

J.1527-3458.2001.TB00188.X

P1433

CNS Neuroscience & Therapeutics

P1476

The Selective Serotonin Reupta ...... d Use in Psychiatric Disorders

@en

P2093

Glenda MacQueen

http://www.w3.org/2001/XMLSchema#string

Leslie Born

http://www.w3.org/2001/XMLSchema#string

Meir Steiner

http://www.w3.org/2001/XMLSchema#string

P2860

The serotonin syndrome.

A molecular and cellular theory of depression.

Neurologic effects of tryptophan in patients receiving a monoamine oxidase inhibitor.

Serotonin syndrome.

Lamotrigine toxicity secondary to sertraline.

Treatment of primary dysthymia with group cognitive therapy and pharmacotherapy: clinical symptoms and functional impairments.

Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder.

A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia.

SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients.

The Norwegian naturalistic treatment study of depression in general practice (NORDEP)-I: randomised double blind study.

P304

1-24

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1527-3458.2001.TB00188.X

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2006-06-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11919013

http://www.w3.org/2001/XMLSchema#string

P921